UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
May 4, 2010
TYCO HEALTHCARE GROUP LP AND MALLINCKRODT INC., PLAINTIFFS,
MUTUAL PHARMACEUTICAL COMPANY, INC. AND UNITED RESEARCH LABORATORIES, INC., DEFENDANTS.
The opinion of the court was delivered by: Chesler, U.S.D.J.
This matter comes before the Court on five motions: 1) the motion for summary judgment of invalidity for improper inventorship and derivation by Mutual Pharmaceutical Company, Inc. and United Research Laboratories, Inc. (collectively, "Mutual"); 2) Mutual's motion for summary judgment of noninfringement; 3) Mutual's motion for summary judgment of obviousness; 4) the cross-motion for partial summary judgment of invalidity for improper inventorship and derivation by Plaintiffs Tyco Healthcare Group LP and Mallinckrodt Inc. (collectively, "Tyco"); and 5) Tyco's cross-motion for partial summary judgment of obviousness; and the Court having considered the parties' submissions; and for the reasons stated in the accompanying Opinion, and good cause appearing
IT IS on this 4th day of May, 2010,
ORDERED that Mutual's motion for summary judgment (Docket Entry No. 325) is GRANTED; and it is further
ORDERED that the remaining motions and cross-motions for summary judgment (Docket Entry Nos. 320, 323, 340, and 346) are DENIED as moot; and it is further
ORDERED that, pursuant to 35 U.S.C. § 103(a), U.S. Patent No. 5,211,954 is invalid for obviousness.
STANLEY R. CHESLER, U.S.D.J.
© 1992-2010 VersusLaw Inc.